Our strength lies in combining scientific domain knowledge with IT expertise to turn fragmented laboratory information into structured, compliant and reusable scientific intelligence
Santhosh Reddy Nella, Managing Director
Pharmaceutical laboratories are generating more data than ever, yet the ability to retrieve, interpret and reuse that information remains uneven. The challenge is particularly relevant across chemistry functions such as Process R&D, Analytical Chemistry and Formulation Development, where experiments, analytical results and development records generate substantial scientific information.
Much of this data continues to sit across paper notebooks, spreadsheets and disconnected applications. As laboratories move toward automation, AI-assisted research and faster decision-making, such fragmentation is becoming a barrier to scientific productivity and data integrity.
Vincatis Technologies Private Limited is addressing this gap through laboratory informatics that is practical, adaptable and accessible. ChemVault is a Laboratory Information Management System (LIMS) with an integrated Electronic Laboratory Notebook (ELN), purpose-built to support chemistry functions within pharmaceutical organisations.
The platform enables laboratories to streamline workflows, improve data integrity and traceability, and drive operational excellence across Chemistry R&D and laboratory operations. The focus is straightforward: helping laboratories organise scientific information, strengthen traceability and reduce administrative effort without forcing scientists to abandon established workflows.
Underpinning this approach is Vincatis’ combination of scientific domain knowledge and IT expertise, which enables the team to understand laboratory requirements and translate them into practical technology solutions.
The Data Problem Goes Beyond Digitization
ChemVault combines LIMS capabilities for managing laboratory information with an integrated ELN for recording experimental work, creating a connected digital environment for scientific activities. “Vincatis views this as one of the industry's fundamental digital gaps. Our objective is to make scientific information easier to capture, retrieve and connect with laboratory workflows”, says Santhosh Reddy Nella, Managing Director.
Another persistent challenge is the coexistence of spreadsheets, notebooks, separate applications and disconnected instruments. While each may support an individual task, collectively they create information silos.
Within Process R&D, Analytical Chemistry, Formulation Development and Peptide Synthesis, scientists frequently need to revisit previous experiments, compare results, track samples or understand why particular development decisions were made. When information is distributed across multiple sources, considerable scientific time can be spent simply reconstructing an experiment or project.
This is where Vincatis considers its scientific IT expertise a significant differentiator. Its team understands both laboratory processes and the scientific requirements behind them, allowing it to grasp customer needs quickly rather than approaching implementation purely as a software exercise.
That understanding can then be translated into technology configurations aligned with the laboratory’s actual working environment. The combination also enables Vincatis to deliver solutions with a rapid turnaround time while retaining the quality and flexibility expected by customers—an approach that has helped the company serve leading global pharmaceutical organisations.
Our strength lies in combining scientific domain knowledge with IT expertise to turn fragmented laboratory information into structured, compliant and reusable scientific intelligenceSanthosh Reddy Nella, Managing Director
For laboratory management, the benefit extends beyond individual workflows. Structured and connected information can reduce dependence on teams manually consolidating data for reviews, planning and decision-making.
At the same time, Vincatis recognises that smaller and mid-sized pharmaceutical companies can remain cautious about informatics investments because of licensing costs, infrastructure requirements, customisation and lengthy implementation cycles.
Vincatis addresses this through a perpetual licensing model and a workflow-oriented implementation approach. Rather than forcing laboratories into rigid predefined processes, ChemVault can be configured around customer SOPs and existing laboratory workflows. The intent is to make digitalisation fit the laboratory, rather than requiring the laboratory to redesign established scientific processes around the software.
Compliance and Data Integrity by Design
In regulated pharmaceutical environments, laboratory digitalisation cannot be separated from compliance. ChemVault has been developed to support requirements associated with 21 CFR Part 11, which governs electronic records and electronic signatures in regulated environments.
Its data-management approach also supports ALCOA/ ALCOA+ data integrity principles, which become increasingly important as laboratories move from paper-based documentation toward interconnected digital environments.
Through role-based access, users can be assigned permissions according to their responsibilities. Scientists can enter experimental information, managers can review project-level data, and administrators can maintain broader oversight. Audit trails, user-linked activities, timestamps and controlled electronic records provide traceability around how laboratory information is created, reviewed and modified.
By integrating LIMS and ELN capabilities, ChemVault aims to connect sample management, experiment management, analytical information, documentation and reporting within a traceable environment. The platform is also supported by a calculation engine, further bringing laboratory activities into a controlled digital workflow. The objective is to support regulatory discipline without allowing compliance processes to become another administrative burden for scientists.
Building for AI-Ready Laboratories and Manufacturing
The next stage of laboratory digitalisation will increasingly involve instrument connectivity, APIs, automation, analytics and AI. Vincatis sees structured data, accessible historical records and traceable workflows as prerequisites for meaningful AI adoption.
For chemistry teams, systematically captured experimental and analytical information can gradually become institutional scientific knowledge. Searchable historical data can enable scientists to compare previous work, identify patterns and build a stronger foundation for advanced analytics and AI-supported research.
Looking ahead, Vincatis plans to further strengthen ChemVault while reducing implementation complexity and making laboratory digitalisation economically viable for organisations that may find large commercial platforms difficult to adopt.
The company is also broadening its portfolio with a new product focused on pharmaceutical manufacturing teams, tentatively planned for launch in October 2026. This will extend Vincatis’ digitalisation focus from chemistry laboratories into pharmaceutical manufacturing operations, creating a broader technology portfolio around scientific and operational workflows.
What makes Vincatis relevant is not simply the digitisation of laboratory records, but the combination of chemistry-focused informatics, scientific IT expertise and an implementation model designed around actual laboratory processes.
By bringing LIMS and ELN capabilities together while keeping 21 CFR Part 11 compliance and ALCOA/ALCOA+ data integrity principles central to its approach, Vincatis is positioning ChemVault as a practical bridge between fragmented laboratory information and the connected, AI-ready scientific environments pharmaceutical organisations are moving toward.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")